The Thierry Latran Foundation was established in 2008 to : (1) finance basic, applied and clinical research with potential therapeutic benefits to sporadic ALS (Amyotrophic Lateral Sclerosis) and (2) support academic and industrial scientific research efforts in Europe to cure this disease. The Foundation has reached significant milestone in terms of understanding ALS disease mechanisms and developments. Thanks to the donors of Friends of Fondation de France donors, we can focus on the most promising therapeutic targets.
Photo: © C. Charzat / Fondation de France